Ananda Pharma Plc (AQU:ANA)

Ananda Pharma Balance Sheet

Financials in millions GBP. Fiscal year is February - January.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Cash & Equivalents	1.66	0.08	0.02	-	-
Cash & Short-Term Investments	1.66	0.08	0.02	-	-
Cash Growth	1870.96%	348.22%	-	-	-
Accounts Receivable	0	-	-	-	-
Other Receivables	0.1	0.05	0.18	0.09	0
Receivables	0.1	0.05	0.18	0.09	0
Prepaid Expenses	0.05	0.03	0.03	0.02	0.01
Other Current Assets	-	-	0.05	-	0
Total Current Assets	1.82	0.16	0.28	0.11	0.01
Property, Plant & Equipment	1.36	1.57	1.76	-	-
Long-Term Investments	-	-	-	2.25	1.28
Goodwill	1.27	1.68	1.27	-	-
Other Intangible Assets	0.18	0.2	3.2	-	-
Total Assets	4.63	3.6	6.51	2.36	1.29
Accounts Payable	0.05	0.06	0.1	0.07	0.02
Accrued Expenses	1.13	0.94	0.68	0.42	0.18
Short-Term Debt	0.47	1.49	0.76	1	0.27
Current Portion of Long-Term Debt	0.74	0.64	2.92	-	-
Current Income Taxes Payable	0	0	-	-	-
Other Current Liabilities	0.06	0.08	0.04	0	0
Total Current Liabilities	2.45	3.2	4.51	1.49	0.46
Long-Term Debt	-	-	-	0.59	-
Long-Term Deferred Tax Liabilities	0.05	0.05	0.79	-	-
Total Liabilities	2.5	3.25	5.3	2.08	0.46
Common Stock	8.6	5.76	2.34	1.6	0.93
Additional Paid-In Capital	6.77	5.33	3.47	0.88	0.69
Retained Earnings	-13.47	-10.78	-4.64	-2.2	-1.23
Comprehensive Income & Other	0.22	0.05	0.03	0.02	0.45
Shareholders' Equity	2.13	0.35	1.2	0.29	0.83
Total Liabilities & Equity	4.63	3.6	6.51	2.36	1.29
Total Debt	1.21	2.12	3.68	1.59	0.27
Net Cash (Debt)	0.45	-2.04	-3.66	-1.59	-0.27
Net Cash Per Share	0.00	-0.00	-0.00	-0.00	-0.00
Filing Date Shares Outstanding	4,299	2,878	1,171	799.02	464.14
Total Common Shares Outstanding	4,299	2,878	1,171	798.52	464.14
Working Capital	-0.63	-3.04	-4.24	-1.38	-0.45
Book Value Per Share	0.00	0.00	0.00	0.00	0.00
Tangible Book Value	0.69	-1.52	-3.27	0.29	0.83
Tangible Book Value Per Share	0.00	-0.00	-0.00	0.00	0.00
Buildings	0.74	0.74	0.74	-	-
Machinery	0.86	0.86	0.86	-	-

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.